| Major apoptotic mechanisms and genes involved in apoptosis Y Kiraz, A Adan, M Kartal Yandim, Y Baran Tumor Biology 37, 8471-8486, 2016 | 563 | 2016 |
| Molecular mechanisms of drug resistance and its reversal in cancer M Kartal-Yandim, A Adan-Gokbulut, Y Baran Critical reviews in biotechnology 36 (4), 716-726, 2016 | 329 | 2016 |
| Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer M Kartal Yandım, E Apohan, Y Baran Cancer chemotherapy and pharmacology 71, 13-20, 2013 | 70 | 2013 |
| Novel agents targeting bioactive sphingolipids for the treatment of cancer A Adan-Gokbulut, M Kartal-Yandim, G İskender, Y Baran Current medicinal chemistry 20 (1), 108-122, 2013 | 68 | 2013 |
| Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells M Kartal, G Saydam, F Sahin, Y Baran Nutrition and cancer 63 (4), 637-644, 2011 | 60 | 2011 |
| Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells CB Avci, S Yilmaz, ZO Dogan, G Saydam, Y Dodurga, HA Ekiz, M Kartal, ... Hematology 16 (5), 303-307, 2011 | 49 | 2011 |
| New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma I Kozanoglu, MK Yandim, ZB Cincin, H Ozdogu, B Cakmakoglu, Y Baran Journal of cancer research and clinical oncology 139, 327-335, 2013 | 40 | 2013 |
| Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells G Can, Z Cakir, M Kartal, U Gunduz, Y Baran Anticancer Research 32 (7), 2673-2678, 2012 | 37 | 2012 |
| Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response … BT Kaymaz, NS Günel, M Ceyhan, VB Çetintaş, B Özel, MK Yandım, ... Tumor Biology 36, 7915-7927, 2015 | 29 | 2015 |
| Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells B Kosova, B Tezcanli, HA Ekiz, Z Cakir, N Selvi, A Dalmizrak, M Kartal, ... Leukemia & lymphoma 51 (10), 1895-1901, 2010 | 27 | 2010 |
| Antioxidant enzyme and element status in heroin addiction or heroin withdrawal in rats: effect of melatonin and vitamin E plus Se M Cemek, ME Büyükokuroğlu, Ö Hazman, S Bulut, M Konuk, Y Birdane Biological trace element research 139, 41-54, 2011 | 25 | 2011 |
| Effects of cell-mediated osteoprotegerin gene transfer and mesenchymal stem cell applications on orthodontically induced root resorption of rat teeth NG Amuk, G Kurt, Y Baran, V Seyrantepe, MK Yandim, A Adan, SA Demir, ... European Journal of Orthodontics 39 (3), 235-242, 2017 | 22 | 2017 |
| STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells HD Kiper, BT Kaymaz, AA Gokbulut, N Selvi, CB Avci, B Kosova, ... Biomedicine & Pharmacotherapy 67 (6), 527-532, 2013 | 19 | 2013 |
| Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line Ö Tüfekçi, MK Yandım, H Ören, G İrken, Y Baran Leukemia research 39 (3), 342-347, 2015 | 10 | 2015 |
| A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib MK Yandim, C Ceylan, E Elmas, Y Baran Tumor Biology 37, 2365-2378, 2016 | 9 | 2016 |
| Effects of intraperitoneal injection of allogeneic bone marrow-derived mesenchymal stem cells on bronchiolitis obliterans in mice model S Işık, N Uzuner, M Karaman, Ö Karaman, M Kıray, İ Kozanoğlu, ... Iranian Journal of Allergy, Asthma and Immunology, 205-218, 2017 | 4 | 2017 |
| A minimally invasive transfer method of mesenchymal stem cells to the intactperiodontal ligament of rat teeth: a preliminary study NG Amuk, G Kurt, MK Yandim, A Adan, Y Baran Turkish Journal of Biology 42 (5), 382-391, 2018 | 3 | 2018 |
| Increasing intracellular generation or accumulation of ceramides increased cytotoxic effects of resveratrol in human K562 chronic myeloid leukemia cells M Kartal Yandım, G Saydam, F Şahin, Y Baran Haematologica, 2009 | 3 | 2009 |
| Targeting FOXM1 Transcription Factor In T-Cell Acute Lymphoblastic Leukemia Ö Tüfekçi, MK Yandım, H Ören, G Irken, Y Baran Blood 122 (21), 4974, 2013 | 2 | 2013 |
| Shotgun Lipidomics Elucidates the Lipidome Alterations of the Mcl-1 Inhibitor S63845 in AML Cell Lines with a Focus on Sphingolipids MK Yandim, M Bilgin Experimed 12 (3), 209-214, 2022 | 1 | 2022 |
